Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)
Titel:
Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM)
Auteur:
Holmsten, Karin Jensen, Niels Viggo Mouritsen, Lene Sonne Jonsson, Erika Mellnert, Camilla Agerbæk, Mads Nilsson, Cecilia Moe, Mette Carus, Andreas Öfverholm, Elisabeth Lahdenperä, Outi Brandberg, Yvonne Johansson, Hemming Hellström, Mats Maase, Hans von der Pappot, Helle Ullén, Anders